Nuvectra Corporation (NVTR) Given Daily Media Sentiment Rating of 0.12
Media coverage about Nuvectra Corporation (NASDAQ:NVTR) has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Nuvectra Corporation earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave news articles about the company an impact score of 45.7036193758355 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Nuvectra Corporation (NVTR) traded up 5.257% during mid-day trading on Monday, reaching $12.715. The company’s stock had a trading volume of 44,847 shares. Nuvectra Corporation has a 12-month low of $4.63 and a 12-month high of $12.73. The company has a 50-day moving average price of $11.56 and a 200-day moving average price of $11.56. The firm’s market cap is $136.04 million.
Nuvectra Corporation (NASDAQ:NVTR) last announced its earnings results on Tuesday, August 8th. The company reported ($1.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.14) by $0.07. The business had revenue of $7.20 million during the quarter, compared to analyst estimates of $5.96 million. Nuvectra Corporation had a negative net margin of 232.31% and a negative return on equity of 56.68%. The company’s quarterly revenue was up 188.0% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.85) EPS. On average, equities research analysts expect that Nuvectra Corporation will post ($4.77) earnings per share for the current year.
NVTR has been the subject of a number of recent research reports. TheStreet raised Nuvectra Corporation from a “d” rating to a “c-” rating in a research report on Monday, June 19th. Zacks Investment Research raised Nuvectra Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, May 30th. ValuEngine raised Nuvectra Corporation from a “sell” rating to a “hold” rating in a research report on Friday, June 16th. Finally, Piper Jaffray Companies reissued a “neutral” rating and issued a $14.00 target price on shares of Nuvectra Corporation in a research report on Thursday, July 6th. Three investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Nuvectra Corporation has an average rating of “Hold” and a consensus price target of $10.50.
ILLEGAL ACTIVITY WARNING: “Nuvectra Corporation (NVTR) Given Daily Media Sentiment Rating of 0.12” was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://www.watchlistnews.com/nuvectra-corporation-nvtr-given-daily-media-sentiment-rating-of-0-12/1587510.html.
In related news, CEO Scott F. Drees bought 10,000 shares of the firm’s stock in a transaction on Friday, August 11th. The stock was acquired at an average cost of $11.72 per share, for a total transaction of $117,200.00. Following the purchase, the chief executive officer now owns 125,180 shares in the company, valued at $1,467,109.60. The acquisition was disclosed in a filing with the SEC, which is available through this link. 3.60% of the stock is currently owned by insiders.
About Nuvectra Corporation
Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.
Receive News & Ratings for Nuvectra Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.